Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis

Fritz Sörgel, Jakob J. Malin, Henning Hagmann, Martina Kinzig, Muhammad Bilal, Dennis A. Eichenauer, Oliver Scherf-Clavel, Alexander Simonis, Lobna El Tabei, Uwe Fuhr, Jan Rybniker
doi: https://doi.org/10.1101/2020.10.28.20216887
Fritz Sörgel
1IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562 Nürnberg-Heroldsberg, Germany
2Institute of Pharmacology, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jakob J. Malin
3Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
5German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henning Hagmann
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
6Department II of Internal Medicine, University Hospital Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Kinzig
1IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562 Nürnberg-Heroldsberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad Bilal
7Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis A. Eichenauer
8University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Intensive Care Program, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Scherf-Clavel
1IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562 Nürnberg-Heroldsberg, Germany
9University of Wuerzburg, Institute for Pharmacy and Food Chemistry, Wuerzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Simonis
3Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lobna El Tabei
7Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Fuhr
7Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.rybniker@uk-koeln.de uwe.fuhr@uk-koeln.de
Jan Rybniker
3Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
5German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.rybniker@uk-koeln.de uwe.fuhr@uk-koeln.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: November 2020 to May 2022

AbstractFullPdf
Nov 202083996347
Dec 2020303604222
Jan 2021166557128
Feb 202112117238
Mar 202111314433
Apr 202113220130
May 20218015528
Jun 20215710719
Jul 2021407320
Aug 20213919430
Sep 20215916435
Oct 202114811329
Nov 20215810222
Dec 20213511711
Jan 20222919020
Feb 2022241258
Mar 202216505
Apr 202238408
May 2022165312
Back to top
PreviousNext
Posted November 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis
Fritz Sörgel, Jakob J. Malin, Henning Hagmann, Martina Kinzig, Muhammad Bilal, Dennis A. Eichenauer, Oliver Scherf-Clavel, Alexander Simonis, Lobna El Tabei, Uwe Fuhr, Jan Rybniker
medRxiv 2020.10.28.20216887; doi: https://doi.org/10.1101/2020.10.28.20216887
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis
Fritz Sörgel, Jakob J. Malin, Henning Hagmann, Martina Kinzig, Muhammad Bilal, Dennis A. Eichenauer, Oliver Scherf-Clavel, Alexander Simonis, Lobna El Tabei, Uwe Fuhr, Jan Rybniker
medRxiv 2020.10.28.20216887; doi: https://doi.org/10.1101/2020.10.28.20216887

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (160)
  • Allergy and Immunology (413)
  • Anesthesia (90)
  • Cardiovascular Medicine (855)
  • Dentistry and Oral Medicine (158)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8547)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1742)
  • Geriatric Medicine (167)
  • Health Economics (371)
  • Health Informatics (1237)
  • Health Policy (619)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10279)
  • Intensive Care and Critical Care Medicine (552)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (210)
  • Neurology (1669)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (325)
  • Occupational and Environmental Health (450)
  • Oncology (926)
  • Ophthalmology (263)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (246)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1763)
  • Public and Global Health (3832)
  • Radiology and Imaging (622)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (207)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (157)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (74)